These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38452919)

  • 1. Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease.
    de Cos M; Mosoyan G; Chauhan K; Troost JP; Wong JS; Lefferts S; Morgan P; Meliambro K; Egerman M; Ray J; Parker T; Levine D; Seshan S; Bardash Y; Horowitz B; Kent CA; Shaw MM; Perlman A; Moledina DG; Coca SG; Campbell KN
    Am J Kidney Dis; 2024 Aug; 84(2):205-214.e1. PubMed ID: 38452919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
    Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L
    FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
    Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
    Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
    Wang CS; Glenn DA; Helmuth M; Smith AR; Bomback AS; Canetta PA; Coppock GM; Khalid M; Tuttle KR; Bou-Matar R; Greenbaum LA; Robinson BM; Holzman LB; Smoyer WE; Rheault MN; Gipson D; Mariani LH;
    Am J Kidney Dis; 2024 Jan; 83(1):37-46. PubMed ID: 37657635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Plasmin(ogen) as a Prognostic Factor for Hypertension.
    Ray EC; Miller RG; Demko JE; Costacou T; Kinlough CL; Demko CL; Unruh ML; Orchard TJ; Kleyman TR
    Kidney Int Rep; 2018 Nov; 3(6):1434-1442. PubMed ID: 30450470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection-Related Acute Care Events among Patients with Glomerular Disease.
    Glenn DA; Henderson CD; O'Shaughnessy M; Hu Y; Bomback A; Gibson K; Greenbaum LA; Zee J; Mariani L; Falk R; Hogan S; Mottl A;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1749-1761. PubMed ID: 33082200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
    Canney M; Gunning HM; Zheng Y; Rose C; Jauhal A; Hur SA; Sahota A; Reich HN; Barbour SJ
    Am J Kidney Dis; 2022 Dec; 80(6):740-750. PubMed ID: 35659570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Plasminuria with Overhydration in Patients with CKD.
    Schork A; Woern M; Kalbacher H; Voelter W; Nacken R; Bertog M; Haerteis S; Korbmacher C; Heyne N; Peter A; Häring HU; Artunc F
    Clin J Am Soc Nephrol; 2016 May; 11(5):761-769. PubMed ID: 26933188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Urinary Plasminogen-Plasmin with Edema and Epithelial Sodium Channel Activation in Patients with Nephrotic Syndrome.
    Chen JL; Wang L; Yao XM; Zang YJ; Wang Y; Li ZJ; Pearce D; Wang H
    Am J Nephrol; 2019; 50(2):92-104. PubMed ID: 31269481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine albumin is a superior predictor of preeclampsia compared to urine plasminogen in type I diabetes patients.
    Nielsen LH; Jensen BL; Fuglsang J; Andersen LLT; Jensen DM; Jørgensen JS; Kitlen G; Ovesen P
    J Am Soc Hypertens; 2018 Feb; 12(2):97-107. PubMed ID: 29305116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
    Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
    Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.
    Spinale JM; Mariani LH; Kapoor S; Zhang J; Weyant R; Song PX; Wong HN; Troost JP; Gadegbeku CA; Gipson DS; Kretzler M; Nihalani D; Holzman LB;
    Kidney Int; 2015 Mar; 87(3):564-74. PubMed ID: 25354239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
    Troost JP; Trachtman H; Spino C; Kaskel FJ; Friedman A; Moxey-Mims MM; Fine RN; Gassman JJ; Kopp JB; Walsh L; Wang R; Gipson DS
    Am J Kidney Dis; 2021 Feb; 77(2):216-225. PubMed ID: 32791086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of urinary C4d is associated with disease progression in IgA nephropathy with glomerular crescentic lesions: a cohort study.
    Wang Z; Jiang Y; Chen P; Wang J; Zhang X; Huang B; Zhou X; Shi S; Liu L; Lv J; Zhang H
    Nephrol Dial Transplant; 2022 Oct; 37(11):2119-2127. PubMed ID: 35104893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
    Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.